Finance

GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE grou By Investing.com

GC Cell and PT Bifarma Adiluhung announced a strategic partnership to facilitate the entry of 'Immuncell-LC', the only approved autologous T-cell therapy for...

Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its Shareholders

WASHINGTON, June 19, 2024 /PRNewswire/ -- Vanda (NASDAQ:) Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the Company's Board of Directors (the "Board"),...

Catalyst repays convertible note, leaving only 2,590oz of debt remaining By Investing.com

Balance sheet repair over previous 12 months has repaid A$28m of debt inherited through the Plutonic Gold Belt consolidationWhen Catalyst acquired ASX listed...

Brent rises on Middle East war jitters, while WTI dips ahead of inventories report By Reuters

By Laila Kearney (Reuters) - futures edged up in early trade on Thursday as Israeli tanks advanced into Gaza, while ...

Nutanix CFO sells over $668k in company stock By Investing.com

SAN JOSE, CA – Nutanix, Inc. (NASDAQ:), a leader in enterprise cloud computing, recently disclosed a series of transactions by its Chief Financial...

Nutanix COO Sangster sells over $562k in company stock By Investing.com

Nutanix, Inc. (NASDAQ:) Chief Operating Officer, David Sangster, has recently engaged in significant trading of company stock, as per the latest SEC filings....

ADC Therapeutics director sells shares worth over $3,400 By Investing.com

ADC Therapeutics SA (NYSE:ADCT) has reported a recent transaction involving the sale of company shares by Director Peter Hug. According to the latest...

Illinois Republican party chair resigns, blames party infighting By Reuters

WASHINGTON (Reuters) -Illinois Republican party chairman Don Tracy resigned on Wednesday, less than a month before next month's Republican National Convention in...

Madrigal Pharmaceuticals senior VP sells $532,000 in stock By Investing.com

In a recent transaction on June 14, Robert E. Waltermire, Senior Vice President and Chief of Pharmaceutical Development at Madrigal Pharmaceuticals, Inc. (NASDAQ:),...

Latest articles

spot_imgspot_img